Bal Pharma Complete Financial Statements
BALPHARMA • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Bal Pharma (BALPHARMA).
Downloads include all available records across all periods.
For market performance, see the
BALPHARMA stock price today
.
Profitability Ratios
Net Profit Margin
1.33%
2025 data
EBITDA Margin
9.33%
2025 data
Operating Margin
8.00%
2025 data
Return on Assets
0.30%
2025 data
Return on Equity
1.30%
2025 data
Balance Sheet Ratios
Current Ratio
6.03
2025 data
Debt to Equity
4.36
2025 data
Equity Ratio
22.92%
2025 data
Asset Turnover
0.22
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+1.4%
Year-over-Year
EBITDA Growth
-12.5%
Year-over-Year
Expense Growth
+3.0%
Year-over-Year
Assets Growth
+5.0%
Year-over-Year
Equity Growth
+6.9%
Year-over-Year
Liabilities Growth
+5.0%
Year-over-Year
Operating Cash Flow Growth
-13.0%
Year-over-Year
Investing Cash Flow Growth
+21.1%
Year-over-Year
Financing Cash Flow Growth
-700.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Mar 2017 | Dec 2017 | Sept 2016 | Mar 2016 | Jun 2016 | Dec 2016 | Sept 2015 | Mar 2015 | Jun 2015 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 75 | 83 | 67 | 74 | 97 | 75 | 74 | 93 | 83 | 71 | 82 | 75 | 78 | 70 | 77 | 68 | 72 | 71 | 70 | 65 | 35 | 52 | 63 | 45 | 54 | 49 | 44 | 58 | 56 | 54 | 54 | 65 | 52 | 66 | 54 | 45 | 58 | 57 | 51 | 41 | 48 |
| Expenses | 68 | 74 | 60 | 66 | 85 | 68 | 65 | 85 | 74 | 64 | 74 | 70 | 71 | 65 | 71 | 61 | 65 | 63 | 63 | 58 | 33 | 47 | 57 | 43 | 49 | 48 | 43 | 53 | 50 | 50 | 50 | 61 | 47 | 62 | 53 | 41 | 55 | 52 | 47 | 38 | 43 |
| EBITDA | 7 | 9 | 7 | 8 | 12 | 7 | 8 | 8 | 8 | 7 | 8 | 6 | 7 | 5 | 7 | 7 | 7 | 8 | 7 | 7 | 2 | 5 | 6 | 2 | 5 | 2 | 1 | 4 | 5 | 5 | 5 | 4 | 5 | 4 | 1 | 4 | 3 | 4 | 3 | 3 | 5 |
| Operating Profit Margin % | 8.00% | 9.00% | 9.00% | 10.00% | 10.00% | 9.00% | 11.00% | 8.00% | 10.00% | 9.00% | 10.00% | 8.00% | 5.00% | 7.00% | 8.00% | 9.00% | 9.00% | 11.00% | 9.00% | 11.00% | 2.00% | 10.00% | 9.00% | 4.00% | 11.00% | 3.00% | 2.00% | 7.00% | 8.00% | 7.00% | 7.00% | 5.00% | 9.00% | 4.00% | 2.00% | 6.00% | 4.00% | 6.00% | 5.00% | 6.00% | 10.00% |
| Depreciation | 2 | 2 | 3 | 3 | 2 | 2 | 3 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 3 | 2 | 3 | 2 | 2 | 2 | 4 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 2 | 2 | 1 | 2 | 4 | 2 | 2 |
| Interest | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 2 |
| Profit Before Tax | 1 | 3 | 0 | 1 | 6 | 1 | 1 | 2 | 2 | 0 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 3 | 2 | 2 | -5 | 1 | 1 | -3 | -1 | -3 | -3 | 0 | 1 | 1 | 1 | -1 | 1 | 2 | -2 | 1 | 0 | 2 | 0 | 0 | 2 |
| Tax | 0 | -3 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | -3 | 1 | 2 | 1 | 0 | 0 | 1 | -1 | -2 | 0 | 1 | 1 | 1 | -1 | -1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 |
| Net Profit | 1 | 5 | 0 | 1 | 6 | 0 | 1 | 1 | 2 | 0 | 1 | 0 | 2 | 0 | 1 | 1 | 4 | 2 | 1 | 1 | -5 | 0 | 0 | -2 | 1 | -3 | -4 | -1 | 1 | 2 | 2 | -2 | 1 | 1 | -3 | 1 | 0 | 2 | 0 | 0 | 1 |
| Earnings Per Share (₹) | 0.45 | 3.40 | 0.13 | 0.65 | 3.73 | 0.16 | 0.33 | 0.62 | 1.03 | 0.06 | 0.54 | 0.08 | 1.33 | 0.19 | 0.38 | 0.97 | 2.52 | 1.09 | 0.32 | 0.30 | -3.21 | 0.30 | 0.22 | -1.29 | 0.77 | -1.74 | -2.52 | -0.53 | 0.45 | 1.12 | 1.12 | -1.29 | 0.24 | 0.12 | -0.24 | 0.04 | 0.43 | 1.52 | 0.26 | 0.21 | 1.52 |
Related Pages for Bal Pharma
Additional stock information and data for BALPHARMA
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 336 | 320 | 313 | 261 | 240 | 238 | 261 | 260 | 233 | 211 | 164 |
| Current Assets | 235 | 234 | 228 | 185 | 164 | 157 | 183 | 185 | 165 | 143 | 105 |
| Fixed Assets | 87 | 80 | 77 | 67 | 69 | 71 | 70 | 72 | 60 | 56 | 52 |
| Capital Work in Progress | 3 | 1 | 0 | 2 | 0 | 3 | 4 | 0 | 2 | 4 | 1 |
| Investments | 3 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 244 | 233 | 237 | 192 | 172 | 164 | 187 | 189 | 172 | 151 | 111 |
| LIABILITIES | |||||||||||
| Total Liabilities | 336 | 320 | 313 | 261 | 240 | 238 | 261 | 260 | 233 | 211 | 164 |
| Current Liabilities | 39 | 45 | 40 | 36 | 34 | 34 | 38 | 46 | 30 | 45 | 16 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 77 | 72 | 64 | 59 | 53 | 45 | 60 | 60 | 60 | 55 | 55 |
| Share Capital | 16 | 16 | 16 | 15 | 15 | 14 | 14 | 14 | 14 | 13 | 13 |
| Reserves & Surplus | 62 | 56 | 48 | 43 | 38 | 38 | 53 | 51 | 48 | 40 | 40 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 20 | 23 | -2 | 27 | 22 | 23 | 8 | 1 | 6 | -19 | 15 |
| Investing Activities | -15 | -19 | -22 | -10 | -6 | -5 | -8 | -4 | -8 | -14 | -5 |
| Financing Activities | -8 | -1 | 24 | -17 | -17 | -20 | 0 | 4 | -6 | 32 | -7 |
| Net Cash Flow | -2 | 3 | 0 | 0 | 0 | -2 | 0 | 1 | -8 | -1 | 2 |